Ann C Collier Selected Research

lamivudine drug combination abacavir

1/2019	Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202.
2/2013	Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202.
10/2011	Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results.
12/2009	Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ann C Collier Research Topics

Disease

30	HIV Infections (HIV Infection) 10/2021 - 08/2002
25	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 06/2007
20	Infections 01/2018 - 03/2004
12	Neurocognitive Disorders (Clerambault Syndrome) 06/2017 - 01/2011
7	Viremia 01/2021 - 11/2010
5	Persistent Infection 07/2011 - 02/2004
4	Pain (Aches) 01/2022 - 01/2014
4	Inflammation (Inflammations) 01/2021 - 01/2017
4	Hepatitis C 12/2015 - 11/2012
3	Neuralgia (Stump Neuralgia) 01/2022 - 01/2014
3	Coinfection 01/2021 - 11/2012
3	Neuroinflammatory Diseases 01/2020 - 01/2017
3	Dementia (Dementias) 04/2016 - 01/2011
2	Polyneuropathies (Polyneuropathy) 01/2022 - 11/2008
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2014 - 11/2008
2	Neoplasms (Cancer) 01/2011 - 06/2005
1	Cognitive Dysfunction 01/2022
1	Overweight 01/2021
1	Obesity 01/2021
1	Hepatitis B 01/2021
1	Weight Gain 01/2021
1	Injection Site Reaction 04/2020
1	Stroke (Strokes) 01/2017
1	Anemia 04/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2015
1	Hyperbilirubinemia 02/2013
1	Substance-Related Disorders (Drug Abuse) 10/2011
1	HIV Seropositivity 08/2011
1	Disease Progression 07/2011
1	Myocardial Infarction 04/2011

Drug/Important Bio-Agent (IBA)

20	RNA (Ribonucleic Acid)IBA 01/2021 - 05/2006
10	Protease Inhibitors (Protease Inhibitor)IBA 01/2019 - 03/2004
9	Ritonavir (Norvir)FDA Link 01/2019 - 03/2004
8	efavirenz (Sustiva)FDA Link 10/2021 - 06/2007
7	Reverse Transcriptase InhibitorsIBA 01/2018 - 02/2006
6	Tenofovir (Viread)FDA Link 01/2021 - 12/2009
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2010
6	Atazanavir Sulfate (Reyataz)FDA Link 01/2019 - 12/2009
6	Pharmaceutical PreparationsIBA 01/2017 - 08/2002
6	VaccinesIBA 10/2015 - 06/2004
5	Emtricitabine (Emtriva)FDA Link 01/2021 - 12/2009
5	NucleosidesIBA 01/2015 - 02/2006
5	Antiviral Agents (Antivirals)IBA 02/2011 - 06/2004
4	lamivudine drug combination abacavir FDA Link 01/2019 - 12/2009
3	abacavir (Ziagen)FDA Link 01/2021 - 06/2006
3	Mitochondrial DNA (mtDNA)IBA 01/2017 - 02/2013
3	Amino Acids FDA Link 12/2012 - 03/2004
2	IntegrasesIBA 01/2021 - 01/2015
2	Darunavir (Prezista)FDA Link 01/2021 - 03/2013
2	Integrase InhibitorsIBA 01/2021 - 01/2015
2	RacivirIBA 01/2021 - 10/2011
2	Biomarkers (Surrogate Marker)IBA 08/2020 - 01/2017
2	Choline (Choline Chloride)IBA 01/2020 - 01/2019
2	Lopinavir FDA Link 01/2018 - 06/2007
2	EnzymesIBA 01/2018 - 08/2011
2	IronIBA 01/2017 - 01/2014
2	Zidovudine (Retrovir)FDA LinkGeneric 04/2016 - 02/2006
2	FHDIBA 01/2016 - 01/2011
2	EpitopesIBA 01/2013 - 12/2009
2	Peptide Hydrolases (Proteases)FDA Link 12/2012 - 04/2008
1	Opioid Analgesics (Opioids)IBA 01/2022
1	Amitriptyline (Elavil)FDA LinkGeneric 01/2022
1	dolutegravirIBA 01/2021
1	bictegravirIBA 01/2021
1	imidazole mustard (BIC)IBA 01/2021
1	Antipsychotic Agents (Antipsychotics)IBA 01/2021
1	InterferonsIBA 01/2020
1	Pain-FreeIBA 01/2020
1	Inosine Monophosphate (IMP)IBA 01/2020
1	N-acetylaspartate (N-acetyl aspartate)IBA 01/2019
1	Inositol (Myoinositol)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2018
1	Immunoglobulin M (IgM)IBA 01/2018
1	AntigensIBA 01/2018
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2017
1	Ceruloplasmin (Ferroxidase)IBA 01/2017
1	Transferrin (beta 2 Transferrin)IBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Interleukin-8 (Interleukin 8)IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Raltegravir Potassium FDA Link 01/2016
1	Proteins (Proteins, Gene)FDA Link 12/2015
1	HIV Protease InhibitorsIBA 09/2014
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2013
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2012
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 11/2012
1	Cysteine (L-Cysteine)FDA Link 04/2012
1	Biological ProductsIBA 08/2011
1	HLA-B57 antigenIBA 07/2011
1	HLA-B Antigens (HLA-B)IBA 07/2011
1	Hepatitis C AntibodiesIBA 06/2011
1	OligonucleotidesIBA 01/2011
1	N-acetoacetyl-N-deacetylcolchicineIBA 01/2011

Therapy/Procedure

23	Therapeutics 01/2022 - 02/2004
17	Highly Active Antiretroviral Therapy (HAART) 06/2017 - 06/2004
4	Art Therapy 01/2020 - 11/2010
1	Pain Management 01/2022
1	Injections 04/2020
1	Activities of Daily Living (ADL) 01/2020
1	Ligation 01/2011